Skip to product information
1 of 1

Elabscience

SKU:E-AB-22190

Galectin 3 Monoclonal Antibody

Galectin 3 Monoclonal Antibody

Regular price $420.00 USD
Regular price Sale price $420.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Concentration
Host

Galectin 3 Monoclonal Antibody

Introducing the Galectin 3 Monoclonal Antibody, a cutting-edge product designed to revolutionize the field of biomedical research. This highly advanced antibody is meticulously engineered to target and bind specifically to Galectin 3, a protein known for its involvement in various physiological and pathological processes.

Crafted with utmost precision and utilizing state-of-the-art technology, this monoclonal antibody offers unparalleled specificity and sensitivity, enabling researchers to delve deeper into the intricate mechanisms underlying Galectin 3-related phenomena. Its exceptional affinity for Galectin 3 ensures reliable and accurate results, facilitating groundbreaking discoveries and advancements in the scientific community.

The Galectin 3 Monoclonal Antibody boasts exceptional versatility, making it an invaluable tool across a wide range of applications. From immunohistochemistry and immunofluorescence to Western blotting and flow cytometry, this antibody seamlessly adapts to diverse experimental techniques, providing researchers with unparalleled flexibility and convenience.

Furthermore, this product is meticulously manufactured in compliance with rigorous quality control standards, ensuring utmost reliability and reproducibility. Each batch undergoes meticulous testing to guarantee consistent performance, empowering researchers to confidently pursue their scientific endeavors.

In summary, the Galectin 3 Monoclonal Antibody represents a groundbreaking advancement in the realm of biomedical research. With its exceptional specificity, sensitivity, and versatility, this product is poised to revolutionize the understanding of Galectin 3-related processes, paving the way for novel therapeutic interventions and improved patient outcomes.

View full details